Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 14 |
---|
Ligand | BDBM50305726 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_604746 (CHEMBL1071905) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Jerome, KD; Rucker, PV; Xing, L; Shieh, HS; Baldus, JE; Selness, SR; Letavic, MA; Braganza, JF; McClure, KF Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition. Bioorg Med Chem Lett20:469-73 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 14 |
---|
Name: | Mitogen-activated protein kinase 14 |
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 41286.76 |
Organism: | Homo sapiens (Human) |
Description: | Q16539 |
Residue: | 360 |
Sequence: | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
|
|
|
BDBM50305726 |
---|
n/a |
---|
Name | BDBM50305726 |
Synonyms: | 6-(2,4-difluorophenylsulfonyl)-3-isopropyl-[1,2,4]triazolo[4,3-a]pyridine | CHEMBL611648 |
Type | Small organic molecule |
Emp. Form. | C15H13F2N3O2S |
Mol. Mass. | 337.344 |
SMILES | CC(C)c1nnc2ccc(cn12)S(=O)(=O)c1ccc(F)cc1F |
Structure |
|